top of page

CONTINUUS awarded SBIR Phase I grant from the NSF

Monday, January 12th, 2015 - General News

CONTINUUS Pharmaceuticals was awarded a Phase I SBIR grant from the National Science Foundation to further develop its breakthrough ICM technology. This Phase I grant consists of $150,000 over a six month period.

Recent Posts

See All

CONTINUUS ON SHOW AT CHPI 2022

Monday, September 26th, 2022 - General News CPHI 2022 is just around the corner and CONTINUUS is pleased to be part of it! From November...

Comments


bottom of page